Cite
APA Citation
Miksad, R., Cicin, I., Chen, Y., Klumpen, H., Kim, S., Lin, Z., Youkstetter, J., Sen, S., Cheng, A., Meyer, T., Kelley, R., & Abou-Alfa, G. (n.d.). o-022Outcomes based on Albumin‐Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC). Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100094625937.0x00002e